Andrzej Jakubowiak to Signaling Lymphocytic Activation Molecule Family
This is a "connection" page, showing publications Andrzej Jakubowiak has written about Signaling Lymphocytic Activation Molecule Family.
Connection Strength
0.178
-
First-in-Human Phase I Study of ABBV-838, an Antibody-Drug Conjugate Targeting SLAMF7/CS1 in Patients with Relapsed and Refractory Multiple Myeloma. Clin Cancer Res. 2020 05 15; 26(10):2308-2317.
Score: 0.178